HBK Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,550,000	Closed	-$537M	–	297
2022 Q3	$537M	Buy	3,550,000 +2,725,000	+330%	+$412M	3.8%	1
2022 Q2	$120M	Buy	+825,000	New	+$120M	0.67%	7
2019 Q3	–	Sell	-80,000	Closed	-$3.5M	–	530
2019 Q2	$3.5M	Buy	+80,000	New	+$3.5M	0.03%	128